Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 073696
Company: WATSON LABS
Company: WATSON LABS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
NITROFURANTOIN | NITROFURANTOIN, MACROCRYSTALLINE | 25MG | CAPSULE;ORAL | Discontinued | None | No | No |
NITROFURANTOIN | NITROFURANTOIN, MACROCRYSTALLINE | 50MG | CAPSULE;ORAL | Discontinued | None | No | No |
NITROFURANTOIN | NITROFURANTOIN, MACROCRYSTALLINE | 100MG | CAPSULE;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
12/31/1992 | ORIG-1 | Approval |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
08/30/1999 | SUPPL-5 | Labeling |
Label is not available on this site. |
||
12/01/1998 | SUPPL-3 | Labeling |
Label is not available on this site. |
||
02/12/1998 | SUPPL-2 | Labeling |
Label is not available on this site. |
||
01/08/1997 | SUPPL-1 | Labeling |
Label is not available on this site. |